NewsRoom Articles - Page 39 of 218

MondayJul 08, 2024 12:00 pm

Astiva Health Inc. Leading the Way as Record Number of People Choose Medicare Advantage Plans

For the first time in Medicare’s history, more than half of all eligible people with Medicare are enrolled in private Medicare Advantage plans Enrollment in Medicare Advantage programs is projected to grow from 54% of the eligible population in 2024 to 60% by the end of the decade Astiva Health has developed one of the most diverse networks in Southern California and offers a selection of benefits tailored to the specialized needs of its members According to a recent KFF report, a record number of people enrolled in private Medicare Advantage plans last year (https://ibn.fm/YEpRJ). That trend bodes well for Astiva Health,…

MondayJul 08, 2024 10:00 am

Research Identifies How Glioblastoma Develops Resistance to Immunotherapy

Glioblastoma multiforme is an aggressive cancer that grows quickly and spreads rapidly, originating as a growth of cells in the spinal cord or the brain. Researchers at the University of Copenhagen may have discovered how this type of cancer, which primarily effects adults, develops resistance to immunotherapy. At first, the researchers thought that the cancer cells changed their DNA via mutation, helping them become treatment resistant. However, the researchers observed that when glioblastoma cells were subjected to immunotherapy, they behaved differently. Joachim Lütken Weischenfeldt, a clinical professor at the Biotech Research and Innovation Center, led this research. For their study,…

FridayJul 05, 2024 10:00 am

Study Suggests AI Models Could Be Relying on ‘Demographic Shortcuts’ During Medical Diagnosis

New research has determined that artificial intelligence (AI) models may be depending on “demographic shortcuts” when making medical diagnoses. Prior studies had determined that these models could reliably predict a patient’s race from their chest X-rays, something even the best radiologists couldn’t do. This has been further put under the spotlight by this recent study, which determined that these artificial intelligence models have discrepancies in their ability to reliably diagnose images of individuals of different races or genders. For their study, the researchers used chest X-ray datasets to train the models to predict if patients either suffered from a collapsed…

FridayJul 05, 2024 9:00 am

Clene Inc. (NASDAQ: CLNN) Presents Promising Preliminary Data on CNM-Au8(R) for Rett Syndrome Treatment

Clene revealed new preliminary data on CNM-Au8 for Rett Syndrome treatment at the International Rett Syndrome Foundation 2024 Annual Meeting in Westminster, Colorado The only current FDA-approved drug for Rett Syndrome is trofinetide, approved in 2023 CNM-Au8 treatment showed improvements in mitochondrial respiration deficits in Rett patient-derived astrocytes Clene (NASDAQ: CLNN), along with its subsidiary Clene Nanomedicine Inc., a biopharmaceutical company specializing in mitochondrial health to address neurological diseases like amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), recently revealed new preliminary data on CNM-Au8 for Rett Syndrome treatment. The data was presented by Dr. Karen Ho, Clene’s Vice President…

WednesdayJul 03, 2024 10:00 am

What to Consider When Choosing Between Traditional Medicare, Medicare Advantage

Medicare Advantage and Traditional Medicare both have their own advantages and disadvantages. Individuals, particularly those aged 65 years of age and older or those retiring, should consider the differences in these insurance plans before deciding on a cover. So, what are the basic differences in the two plans? Medicare Advantage plans are managed by private insurance companies that receive payments from the federal government to offer benefits to individuals in their programs. On the other hand, traditional Medicare is a national program that offers benefits under Medicare. What factors should older individuals and their caregivers think about before they choose…

MondayJul 01, 2024 10:00 am

New Research Suggests More Intervention May Not Increase Benefits for Autistic Kids

Healthcare professionals normally recommend higher intensity interventions when a child is diagnosed with autism, amounting to roughly 40 hours weekly to support their development. Now a new study has determined that additional hours of intervention for autistic children did not offer any increased benefits. The study was led by UNC School of Medicine’s Micheal Sandbank, as well as other investigators across America. For their study, the investigators obtained data from early-childhood intervention studies that involved more than 9,000 kids between 0 and 8 years of age. Once the data was obtained, the researchers carried out a meta-analysis to find out…

FridayJun 28, 2024 10:00 am

New Test Identifies Parkinson’s Before Symptoms Develop

Currently, more than 10 million individuals are affected by Parkinson’s disease around the world. This degenerative condition affects an individual’s nervous system and damages parts of the brain that control movement, causing involuntary shaking and stiff muscles as well as balance problems. In addition to this, the disease also affects a patient’s mental health, causing anxiety and depression, insomnia and memory issues. With the disease’s prevalence, there is an urgent need to develop better preventative strategies and treatments. This has proven difficult, particularly given researchers’ inability to identify individuals at risk of the illness while its in the early stages.…

FridayJun 28, 2024 9:00 am

Annovis Bio Inc. (NYSE: ANVS) Announces Results From Phase II/III Buntanetap Study for the Treatment of Alzheimer’s Disease

Buntanetap is designed to target neurodegeneration by inhibiting the formation of multiple neurotoxic proteins, including amyloid beta, tau, alpha-synuclein, and TDP43 The study demonstrated significant efficacy and safety for buntanetap in a subgroup of early Alzheimer’s patients in both carriers and non-carriers of Apolipoprotein E4 (APOE4), a recognized genetic factor linked to Alzheimer’s Annovis Bio has been selected to present detailed data from its Alzheimer’s study at the Alzheimer’s Association International Conference(R) 2024 June is Alzheimer’s & Brain Awareness Month, a time dedicated to raising awareness about Alzheimer’s disease and other forms of dementia, as well as the importance of…

WednesdayJun 26, 2024 2:00 pm

BioMedNewsBreaks – Tivic Health(R) Systems (NASDAQ: TIVC) Names New Board Member

Tivic Health(R) Systems (NASDAQ: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced the appointment of Christina Valauri to the company’s board of directors, effective July 1, 2024. “Over the past year, as an advisor to our Board and the company, Christina Valauri has demonstrated deep commitment to excellence and the highest standards of ethical governance. This, paired with her insight into capital markets and deep background in research analysis, is a powerful combination to help ensure we make the best decisions for the company, our customers and our shareholders,” TIVC Chair of the Board Sheryle Bolton…

WednesdayJun 26, 2024 10:00 am

Study Finds Infectious Diseases Have Surged Post COVID-19 Pandemic

New research has determined that the global effect of the coronavirus pandemic observed over the last four years has led to a heightened surge of other infectious illnesses. The research was conducted by Airfinity, a data and analytics company based in the United Kingdom, which is focused on monitoring and predicting trends in global public health and disease. This observation suggests that measures imposed by governments globally allowed SARS-CoV-2 to proliferate and infect millions created conditions for even more damage to be done. For its research, the company conducted an analysis which determined that globally, there had been a resurgence…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Astiva Health Inc. Leading the Way as Record Number of People Choose Medicare Advantage Plans

Research Identifies How Glioblastoma Develops Resistance to Immunotherapy

Study Suggests AI Models Could Be Relying on ‘Demographic Shortcuts’ During Medical Diagnosis

Clene Inc. (NASDAQ: CLNN) Presents Promising Preliminary Data on CNM-Au8(R) for Rett Syndrome Treatment

What to Consider When Choosing Between Traditional Medicare, Medicare Advantage

New Research Suggests More Intervention May Not Increase Benefits for Autistic Kids

New Test Identifies Parkinson’s Before Symptoms Develop

Annovis Bio Inc. (NYSE: ANVS) Announces Results From Phase II/III Buntanetap Study for the Treatment of Alzheimer’s Disease

BioMedNewsBreaks – Tivic Health(R) Systems (NASDAQ: TIVC) Names New Board Member

Study Finds Infectious Diseases Have Surged Post COVID-19 Pandemic

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search